Moses Moustakim

423 total citations
7 papers, 137 citations indexed

About

Moses Moustakim is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Moses Moustakim has authored 7 papers receiving a total of 137 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Organic Chemistry and 2 papers in Oncology. Recurrent topics in Moses Moustakim's work include Protein Degradation and Inhibitors (5 papers), Ubiquitin and proteasome pathways (3 papers) and Multiple Myeloma Research and Treatments (2 papers). Moses Moustakim is often cited by papers focused on Protein Degradation and Inhibitors (5 papers), Ubiquitin and proteasome pathways (3 papers) and Multiple Myeloma Research and Treatments (2 papers). Moses Moustakim collaborates with scholars based in United Kingdom, Germany and United States. Moses Moustakim's co-authors include Paul E. Brennan, Darren J. Dixon, Duncan A. Hay, Peter G. K. Clark, Stefan Knapp, Oleg Fedorov, A. Chaikuad, David Heidenreich, Jurema Schmidt and Daniel Merk and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Medicinal Chemistry and Methods in enzymology on CD-ROM/Methods in enzymology.

In The Last Decade

Moses Moustakim

7 papers receiving 135 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Moses Moustakim United Kingdom 6 109 26 22 19 9 7 137
Manjuan Liu United Kingdom 6 120 1.1× 25 1.0× 37 1.7× 18 0.9× 18 2.0× 8 148
John Sapienza Switzerland 3 116 1.1× 44 1.7× 25 1.1× 43 2.3× 8 0.9× 4 154
Anne Cheasty United Kingdom 6 86 0.8× 25 1.0× 21 1.0× 27 1.4× 7 0.8× 8 131
Steven Ferrara United States 6 169 1.6× 12 0.5× 24 1.1× 54 2.8× 9 1.0× 9 236
Jin Zeng China 8 108 1.0× 31 1.2× 6 0.3× 26 1.4× 12 1.3× 10 151
Natalie H. Theodoulou United Kingdom 6 132 1.2× 30 1.2× 69 3.1× 45 2.4× 8 0.9× 7 178
N. Connor Payne United States 9 165 1.5× 36 1.4× 19 0.9× 34 1.8× 3 0.3× 20 215
Sadiya N. Addo United States 6 110 1.0× 31 1.2× 18 0.8× 96 5.1× 12 1.3× 7 204
Anup Aggarwal United States 6 130 1.2× 28 1.1× 16 0.7× 23 1.2× 4 0.4× 9 160
M. Szklarz United Kingdom 3 102 0.9× 25 1.0× 8 0.4× 22 1.2× 15 1.7× 3 180

Countries citing papers authored by Moses Moustakim

Since Specialization
Citations

This map shows the geographic impact of Moses Moustakim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moses Moustakim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moses Moustakim more than expected).

Fields of papers citing papers by Moses Moustakim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moses Moustakim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moses Moustakim. The network helps show where Moses Moustakim may publish in the future.

Co-authorship network of co-authors of Moses Moustakim

This figure shows the co-authorship network connecting the top 25 collaborators of Moses Moustakim. A scholar is included among the top collaborators of Moses Moustakim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moses Moustakim. Moses Moustakim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Wu, Kenneth, Moses Moustakim, Clinton Yu, et al.. (2021). Inhibitors of cullin-RING E3 ubiquitin ligase 4 with antitumor potential. Proceedings of the National Academy of Sciences. 118(8). 19 indexed citations
2.
Moustakim, Moses, et al.. (2020). Photocyclization of enamines to access Spiroindolines and Spirooxindoles in continuous flow. Tetrahedron Letters. 61(28). 152111–152111. 2 indexed citations
3.
Ni, Xiaomin, David Heidenreich, Thomas Christott, et al.. (2019). Structural Insights into Interaction Mechanisms of Alternative Piperazine-urea YEATS Domain Binders in MLLT1. ACS Medicinal Chemistry Letters. 10(12). 1661–1666. 19 indexed citations
4.
Moustakim, Moses, Kerstin Riedel, M. Schuller, et al.. (2018). Discovery of a novel allosteric inhibitor scaffold for polyadenosine-diphosphate-ribose polymerase 14 (PARP14) macrodomain 2. Bioorganic & Medicinal Chemistry. 26(11). 2965–2972. 24 indexed citations
5.
Moustakim, Moses, et al.. (2018). Target Identification Using Chemical Probes. Methods in enzymology on CD-ROM/Methods in enzymology. 610. 27–58. 6 indexed citations
6.
Heidenreich, David, Moses Moustakim, Jurema Schmidt, et al.. (2018). Structure-Based Approach toward Identification of Inhibitory Fragments for Eleven-Nineteen-Leukemia Protein (ENL). Journal of Medicinal Chemistry. 61(23). 10929–10934. 26 indexed citations
7.
Moustakim, Moses, Peter G. K. Clark, Duncan A. Hay, Darren J. Dixon, & Paul E. Brennan. (2016). Chemical probes and inhibitors of bromodomains outside the BET family. MedChemComm. 7(12). 2246–2264. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026